Crude and adjusted analysis of the incidence of decreased glomerular filtration over the 6-year study period, considering Model 1 and Model 2. حسب Camila de Souza dos Santos (17721066)

Means and Cronbach’s alphas for 5C and VAX-measured vaccination attitudes over 12 months. حسب Allyson J. Gallant (9382396)

Cardamonin decreased the protein expression of lipogenic proteins. حسب Peiguang Niu (17044532)

Mean cold pressor threshold overtime (baseline to 12 weeks). حسب Judith I. Tsui (5983160)

الموضوعات:

Mean in cold pressor tolerance overtime (baseline to 12 weeks). حسب Judith I. Tsui (5983160)

الموضوعات:

A summary of calibration standards (n = 3). حسب Ewa Paszkowska (21246702)

الموضوعات:

The observed MRM reactions. حسب Ewa Paszkowska (21246702)

الموضوعات:

Intra- and inter-day precision and accuracy. حسب Ewa Paszkowska (21246702)

الموضوعات:

Association of chemotherapy cycles and nausea and vomiting with the decrease of post-treatment vitamin D concentration (n = 136). حسب Herindita Puspitaningtyas (11618232)

الموضوعات:

The sensitivity analysis results for standardized mean differences of circulating apelin levels between cases with CVDs and controls. حسب Hamed Akbari (8119361)

الموضوعات:

Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae حسب Ziyuan Zhao (2889005)

"…Clinical evaluation showed 100% concordance with qPCR for <i>Ng</i> identification and Sanger sequencing for FC428 strain tracking. …"

Decreased biofilm formation in the Δ<i>tad123</i> mutant cells. حسب Tra-My Duong-Nu (7300970)

Arm tremor and rigidity during settings (mean ± sd). حسب Verneri Ruonala (12419145)

Mean ± SD of the different parameters relative to bipedal stance on soft support with the eyes open recorded in the Chewing and Hand Grip groups. حسب Cristina Dolciotti (16317330)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Long-term anti-nucleocapsid response by baseline patient characteristics. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. حسب Elizabeth S. Munroe (21568166)

الموضوعات: